• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成铁螯合剂对人血清中细菌生长的影响。

The effect of synthetic iron chelators on bacterial growth in human serum.

作者信息

Brock J H, Licéaga J, Kontoghiorghes G J

机构信息

University Department of Bacteriology and Immunology, Western Infirmary, Glasgow, U.K.

出版信息

FEMS Microbiol Immunol. 1988 Jan;1(1):55-60. doi: 10.1111/j.1574-6968.1988.tb02490.x.

DOI:10.1111/j.1574-6968.1988.tb02490.x
PMID:3272827
Abstract

The effect of synthetic iron chelators of the 1-alkyl-3-hydroxy-2-methylpyrid-4-one class (the L1 series) and 1-hydroxypyrid-2-one (L4) on bacterial growth in human serum was compared with those of the plant iron chelators mimosine and maltol and of the microbial siderophore desferrioxamine. None of the synthetic chelators enhanced growth of 3 Gram-negative organisms (Yersinia enterocolitica, Escherichia coli and Pseudomonas aeruginosa); in some cases they were even inhibitory. L4 strongly stimulated growth of Staphylococcus epidermidis, but the L1 series had only a marginal effect. Maltol was mildly inhibitory to all 4 bacterial species, while mimosine enhanced the growth of S. epidermidis and Y. enterocolitica but had little effect on E. coli or P. aeruginosa. Desferrioxamine enhanced the growth of all except E. coli. These results suggest that the chelators of synthetic or plant origin may carry less risk of increasing susceptibility to bacterial infection in patients undergoing chelation therapy for iron overload than does desferrioxamine, the drug currently in clinical use.

摘要

将1-烷基-3-羟基-2-甲基吡啶-4-酮类(L1系列)和1-羟基吡啶-2-酮(L4)的合成铁螯合剂对人血清中细菌生长的影响,与植物铁螯合剂含羞草碱和麦芽酚以及微生物铁载体去铁胺的影响进行了比较。合成螯合剂均未促进3种革兰氏阴性菌(小肠结肠炎耶尔森菌、大肠杆菌和铜绿假单胞菌)的生长;在某些情况下,它们甚至具有抑制作用。L4强烈刺激表皮葡萄球菌的生长,但L1系列只有轻微作用。麦芽酚对所有4种细菌均有轻微抑制作用,而含羞草碱可促进表皮葡萄球菌和小肠结肠炎耶尔森菌的生长,但对大肠杆菌或铜绿假单胞菌几乎没有影响。去铁胺可促进除大肠杆菌外所有细菌的生长。这些结果表明,与目前临床使用的药物去铁胺相比,合成或植物来源的螯合剂在对铁过载进行螯合治疗的患者中,增加细菌感染易感性的风险可能更低。

相似文献

1
The effect of synthetic iron chelators on bacterial growth in human serum.合成铁螯合剂对人血清中细菌生长的影响。
FEMS Microbiol Immunol. 1988 Jan;1(1):55-60. doi: 10.1111/j.1574-6968.1988.tb02490.x.
2
Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.新型1-烷基-3-羟基-2-甲基吡啶-4-酮螯合剂对巨噬细胞摄取和释放铁的影响。
Am J Hematol. 1990 May;34(1):21-5. doi: 10.1002/ajh.2830340106.
3
Radiation sensitization of mammalian cells by metal chelators.金属螯合剂对哺乳动物细胞的辐射增敏作用。
Radiat Res. 2001 Feb;155(2):304-10. doi: 10.1667/0033-7587(2001)155[0304:rsomcb]2.0.co;2.
4
Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.铁螯合剂(儿茶酚、含羞草素、去铁胺和曲酸)对离体新生兔心脏缺血再灌注损伤的保护作用。
Eur Surg Res. 1992;24(6):349-55. doi: 10.1159/000129227.
5
Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.去铁酮、去铁胺及其他螯合剂对铁的竞争以及其他金属的影响。
Arzneimittelforschung. 1993 Jun;43(6):659-63.
6
Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.缺铁会抑制细胞周期蛋白依赖性激酶的活性,并降低异步培养的MDA-MB-453人乳腺癌细胞中细胞周期蛋白D/细胞周期蛋白依赖性激酶4的蛋白质水平。
Exp Cell Res. 1996 Nov 25;229(1):60-8. doi: 10.1006/excr.1996.0343.
7
Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.螯合剂对含铁血黄素、铁蛋白和铁(III)沉淀物中铁动员的比较研究。
Biochem J. 1987 Jan 1;241(1):87-92. doi: 10.1042/bj2410087.
8
The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.铁螯合剂去铁胺和1-烷基-2-甲基-3-羟基吡啶-4-酮在体外可抑制血管前列环素的合成。
Biochem J. 1988 Aug 15;254(1):239-44. doi: 10.1042/bj2540239.
9
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.使用三价麦芽酚铁和其他亲脂性铁螯合剂复合物治疗缺铁性贫血的新时代:发现的历史视角和未来应用。
Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546.
10
Chelators affecting iron absorption in mice.
Arzneimittelforschung. 1990 Dec;40(12):1332-5.

引用本文的文献

1
Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs.药物选择和剂量、医学中的最佳治疗和风险/效益评估:铁螯合剂药物的范例。
Int J Mol Sci. 2023 Nov 25;24(23):16749. doi: 10.3390/ijms242316749.
2
Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications.医学中的铁负荷毒性:从分子和细胞角度到临床意义。
Int J Mol Sci. 2023 Aug 18;24(16):12928. doi: 10.3390/ijms241612928.
3
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.
地拉罗司:一种具有 40 年历史的多靶点药物,可能对 COVID-19 和具有相似症状的疾病具有活性。
Int J Mol Sci. 2022 Jun 16;23(12):6735. doi: 10.3390/ijms23126735.
4
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.使用三价麦芽酚铁和其他亲脂性铁螯合剂复合物治疗缺铁性贫血的新时代:发现的历史视角和未来应用。
Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546.
5
Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections.铁螯合与基于镓的疗法在抗药性细菌感染治疗方面的最新进展。
Int J Mol Sci. 2021 Mar 12;22(6):2876. doi: 10.3390/ijms22062876.
6
Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.铁与螯合作用在生物化学和医学中的应用:控制铁代谢和治疗相关疾病的新方法。
Cells. 2020 Jun 12;9(6):1456. doi: 10.3390/cells9061456.
7
Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology.用于铁过载、其他铁失衡疾病及自由基病理临床治疗的植物螯合剂
Molecules. 2015 Nov 23;20(11):20841-72. doi: 10.3390/molecules201119725.
8
Inhibitors of TonB function identified by a high-throughput screen for inhibitors of iron acquisition in uropathogenic Escherichia coli CFT073.通过高通量筛选尿路致病性大肠杆菌 CFT073 铁摄取抑制剂鉴定的 TonB 功能抑制剂。
mBio. 2014 Feb 25;5(2):e01089-13. doi: 10.1128/mBio.01089-13.
9
The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa.铁、生物膜形成和黏液性之间复杂的相互作用影响铜绿假单胞菌的抗菌耐药性。
Pathog Dis. 2014 Apr;70(3):307-20. doi: 10.1111/2049-632X.12132. Epub 2014 Feb 10.
10
Targeting iron assimilation to develop new antibacterials.靶向铁吸收以开发新型抗菌药物。
Expert Opin Drug Discov. 2012 Sep;7(9):831-47. doi: 10.1517/17460441.2012.708335. Epub 2012 Jul 19.